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Evaluation of stability and in vitro wound healing potential of 
melatonin loaded (lipid enriched) chitosan based microspheres
The aim of this study was to evaluate long-term stability and 
assess the wound healing potential of the innovative 
melatonin-loaded lipid-enriched hybrid system compared to 
conventional melatonin-loaded chitosan microspheres. The 
hybrid system contained nanostructured lipid carrier 
incorporated in the chitosan matrix, in order to modify 
melatonin release and alter physicochemical characteristics of 
the delivery system. Stability testing was performed during a 
six-month period under two conditions: refrigerated (5 ± 3 °C) 
and at room temperature (25 ± 2 °C/60 ± 5 % RH). Samples 
stored at both conditions were analyzed in terms of particle 
size, zeta potential, moisture content and thermal properties. 
At the end of testing, drug content was determined in all 
samples. Dressings wound healing potential was assessed by 
in vitro scratch test using human skin fibroblast cell line. Al-
though both systems showed good stability characteristics, 
the addition of lipids in the system has improved its wound 
healing potential.
Keywords: melatonin, nanoparticles, microspheres, chito-
san, stability, wound healing
Persisting non-healing wounds represent a massive burden for the worldwide health-
care system, with more than 25 billion USD spent per year in the US only (1). Population 
aging, high incidence of obesity and diabetes and a large number of burn injuries are 
recognized as a major cause of increased chronic wound prevalence. Wound healing is a 
well-coordinated physiological process, governed by different cell types and signals. Gene-
rally, healing can be divided into four ordered but overlapping processes of haemostasis, 
inflammation, proliferation and remodelling (2). In most of the cases, the healing process 
is interrupted during the inflammation phase. Although the aetiology is highly variable, 
persistent infection, biofilm formation and reduction of granulation and reepithelialisa-
tion are common characteristics associated with non-healing wounds (3, 4). High incidence 
of chronic wounds accompanied by increasing bacterial resistance justifies enlarged interest 
in the development of nonconventional, more efficient therapies. 
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Melatonin, mainly perceived as the pineal gland hormone, has pleiotropic activities 
as a neurotransmitter, cytokine, biological-response modifier, anti-inflammatory agent 
and free-radical scavenger (5). While full melatonin potential as a cutaneous agent still 
needs to be discovered (6), recent in vitro studies showed a positive impact on corneal and 
diabetic wound healing models (7, 8). Owing to its anti-oxidant and anti-inflammatory 
properties, melatonin shows potential for application in nonconventional dressings for 
burn and chronic wound treatment (9).
Among many nano-sized drug delivery systems, nanostructured lipid carriers (NLCs) 
are highly investigated as wound-healing agents (10). NLCs are nanoparticles composed 
of a blend of solid and liquid lipids (11), with adequate drug loading capacity and stability 
(compared to solid lipid nanoparticles), providing controlled drug release and skin hydra-
tion effect (12). Even though mainly acting as carriers for growth factors or antimicrobial 
agents (12, 13), it was reported that NLCs themselves can promote wound healing in a rat 
burn model (14). 
Chitosan, a linear amino polysaccharide, is widely used as a wound healing promoter, 
due to its antibacterial, haemostatic and mucoadhesive properties (15). Chitosan-based 
dressings in form of gels and films are already present as marketed products, whereas in 
terms of novel systems, chitosan can be formulated as part of artificial skin, powder for-
mulation or coupled to peptides (16). 
Our group has recently verified the idea of combining the above-mentioned compo-
nents for the development of two drug delivery systems for wound management, prepared 
by spray drying technology. The first one refers to fine-tuned melatonin-loaded chitosan/
Pluronic® F127 microspheres characterized by small diameter, positive surface charge, 
efficient melatonin encapsulation and high rate and extent of fluid uptake. Formulated dry 
powder acted as in situ gel-forming dressing with antimicrobial activity, applicable for 
highly exuding wounds (17). In order to alter microparticulate dressing properties, the 
novel lipid-enriched hybrid system was developed, comprising NLCs within the chitosan/
Pluronic® F127 matrix, with melatonin incorporated in both, the NLC and chitosan matrix. 
Influence of formulation and process parameters, on characteristics of prepared lipid and 
hybrid systems, was evaluated using Design of Experiments approach. The optimized 
hybrid system showed prolonged melatonin release and good flowability properties while 
maintaining antimicrobial activity. Reduced swelling and water retaining characteristics 
made it suitable for application to moderate exuding wounds (18). Both systems were 
shown to be biocompatible with skin keratinocytes and fibroblasts (17, 18). 
The aim of this study was to evaluate and compare aforementioned (NLC free and 
NLC enriched, in the further text indicated as MCP and MLCP) melatonin delivery sys-
tems in terms of long-term stability and in vitro wound healing potential. 
There are some literature reports on the stability of spray-dried chitosan-based pow-
ders (19, 20). However, although the conversion of lipid particles to dry powder via spray 
drying has been evaluated by other researchers (21, 22), stability assessment of the lipid 
component and the dry powder over time is scarce (23). Stability testing was performed 
during a six-month period under two conditions: refrigerated (5 ± 3 °C) and at room tem-
perature (25 ± 2 °C/60 ± 5 % RH). Samples stored at both conditions were analysed in terms 
of particle size, zeta potential, moisture content and thermal properties. At the end of the 
testing, drug content was determined in all samples.
Dressings wound healing potential was assessed by completion of in vitro scratch test 
using human skin fibroblast cell line. In vitro scratch assay is a widely used conventional 
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assay that provides insight about formulation influence on cell migration and proliferation 
(24). As fibroblasts play a major role in the healing process during inflammation and re-




Compritol® 888 ATO (glycerol dibehenate) was a kind gift from Gattefosse (France). 
Melatonin (China) and chitosan (≥ 75 % deacetylated powder, Japan) were purchased from 
Sigma-Aldrich. Pluronic® F127 was obtained from BASF (Germany). Miglyol® 812N was 
obtained from Sasol (Germany). All other chemicals and solvents used in the study were 
of analytical grade and procured from Kemika (Croatia) or Sigma-Aldrich.
Preparation of melatonin loaded chitosan/Pluronic® F127 microspheres 
Melatonin loaded chitosan/Pluronic® F127 microspheres (MCP; i.e. NLC free micro-
spheres) were prepared by spray drying method as previously described (17). Briefly, spray 
drying feed was prepared by mixing (i) solution of chitosan (10 g L–1) in 0.5 % acetic acid 
solution with (ii) melatonin and Pluronic® F127 solution prepared in 96 % ethanol. Solu-
tions were mixed at a volume ratio of 4/1, respectively, resulting in the spray drying feed 
with chitosan to melatonin ratio of 2/1 (Table I) and chitosan to Pluronic® F127 ratio of 5/1 
(Table I). Spray drying was performed using a Mini Spray Dryer Büchi 190 (Flawil, Switzer-
land) with an inlet temperature of 145 °C, feed flow rate of 2.59 mL min–1, a standard 0.7 mm 
nozzle and compressed air flow rate of 700 NL h–1.
Preparation of melatonin loaded NLC enriched chitosan/Pluronic® F127 microspheres
Preparation of NLCs: Melatonin loaded NLCs were prepared by hot ultrasonication 
method optimized by our group (18). Briefly, melatonin was dissolved in a Compritol® 888 
ATO/Miglyol® 812N mixture heated to 90 °C, at melatonin to lipid weight ratio of 2/5 (Table 
I). The aqueous phase containing Pluronic® F127 was heated to the same temperature and 
added dropwise to the lipid phase under magnetic stirring. The mass ratio of Pluronic® 
F127 to dispersed lipids in the obtained pre-emulsion was 1/3. Pre-emulsion was then 











Chitosan 58.8 – 46.1 –
Lipids content in the microspheres – – 21.6 2.3/5
Pluronic® F127 11.8 1/5 9.2 1/5
Melatonin content in the microspheres 29.4 1/2 23.1 1/2
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 subjected to probe sonication (UP200Ht Hielscher, Germany) and melatonin loaded NLCs 
were formed after cooling down to room temperature.
Preparation of microspheres. – As described in our previous work (18), spray-drying feed 
for the preparation of melatonin loaded NLC enriched microspheres (MLCP) was prepared 
by dropwise addition of dispersion of melatonin loaded NLCs to chitosan/melatonin/
Pluronic® F127 solution prepared as for above-mentioned NLC free microspheres. The 
volume ratio of NLC dispersion to chitosan/melatonin/Pluronic® F127 solution was set to 
ensure lipid to chitosan mass ratio of 2.3/5 (Table I). Spray drying was performed using a 
ProCept 4M8-TriX Spray Dryer, with an inlet temperature of 110 °C, feed flow rate of 1.8 
mL min–1 with a 0.6 mm nozzle and compressed nitrogen flow rate of 0.3 m3 min–1.
Physico-chemical characteristics of melatonin loaded (NLC enriched) microsphere
Particle size. – NLC free microspheres (MCP) size and distribution were determined 
by microscopic imaging analysis technique, using Olympus BH-2 microscope, equipped 
with a camera (CCD Camera ICD-42E; Ikegami Tsushinki Co., Tokyo, Japan) and computer- 
-controlled image analysis system (Optomax V, Cambridge, UK), with at least 3000 parti-
cles examined. NLC enriched microsphere (MLCP) size and distribution were evaluated 
using a Malvern Morphology G3-ID (Malvern Instruments, UK) with a minimum of 10000 
particles examined.
Zeta potential. – The zeta potential of the microspheres was determined by laser 
Doppler anemometry (Zetasizer 3000HS, Malvern Instruments, UK) at 25 °C, as described 
in our previous work (17). Briefly, microspheres were dispersed in 10 mM NaCl. 
Measurement was performed in an electrophoretic cell under the potential of 150 mV. 
Conversion of the measured electrophoretic mobility to zeta potential using the Helmholtz- 
-Smoluchowski equation was performed within the system software.
Drug loading. – The content of melatonin within the microspheres was determined by 
the HPLC assay method as described previously (18). In short, dispersion of microspheres 
in 1 mol L–1 HCl/acetonitrile mixture (1/1, V/V) was first sonicated, then filtered and dilu ted 
with the mixture of 96 % ethanol and purified water (1/4, V/V).
An HPLC analysis was performed on Agilent 1100 Series instrument (Agilent Tech-
nologies, Germany) equipped with a diode array detector set at 224 nm. The mobile phase 
contained HPLC grade water and acetonitrile in the ratio of 52/48, The column (Kinetex 
C18 column 50 × 4.6 mm2, particle size 5 mm, Phenomenex, USA) suited with an in-line 
filter (KrudKatcher Ultra HPLC, 0.5 µm Depth Filter × 0.004 in, Phenomenex, USA) was 
used. The analysis was performed under chromatographic conditions as follows: sample 
injection volume of 10 µL, isocratic elution, the run time of 1 min, the flow rate of 1 mL min–1 
and the column temperature of 30 °C.
Thermal analyses. – Modulated differential scanning calorimetry (MDSC) analyses 
were performed using a TA Instrument modulated DSC Q2000 (TA Instruments, USA). 
Quantity of about 0.5–1.0 mg of the powder sample was weighed in aluminium standard 
pans. The analysis was performed under dynamic nitrogen atmosphere at the flow rate of 
50 mL min–1. Samples were scanned at the heating rate of 5 °C min–1 from 20 to 220 °C, with 
modulation of ± 1 °C (amplitude) each 60 s (period).
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TGA Q5000 (TA Instruments, USA) was used to determine the moisture content in the 
microsphere samples. Thermogravimetric analysis was performed on the microsphere 
sample (about 5 mg) under dynamic nitrogen atmosphere at a flow rate of 35 mL min–1. The 
samples were analysed at the heating rate of 10 °C min–1 in the temperature range of 25 to 
500 °C.
Stability testing scheme. – Stability testing was performed during a six-month period. 
Sample containers were sealed, protected from light and kept refrigerated (5 ± 3 °C) and at 
room conditions (25 ± 2 °C/60 ± 5 % RH). Samples stored at both conditions were analysed 
in terms of particle size, zeta potential, moisture content and thermal properties. At the 
end of testing, drug content was determined in all samples.
In vitro scratch assay
In vitro scratch assay was performed using Human diploid fibroblast strain MJ90hTERT 
(kindly provided by Dr. Ivica Rubelj, Institute Ruđer Bošković, Zagreb, Croatia) (26), cul-
tured in DMEM medium (GIBCO, UK) under supplementation with 10 % foetal bovine 
serum (FBS, GIBCO) and antimicrobial solution (Sigma-Aldrich).
MJ90hTERT cells were seeded onto 24-well plates and allowed to reach confluence 
over 1 day in DMEM medium supplemented with 10 % FBS. Subsequently, medium was 
removed and replaced with serum-free medium. Next day (24 h later) a straight scratch 
was made with a 100 µL pipette tip, to simulate a wound (27). The cell monolayer was 
washed with HBSS (pH 7.4) to remove detached cells and cell debris. The wound was ex-
posed to MCP and MLCP suspensions, in HBSS pH 7.4 and 6.3, at melatonin concentration 
of 0.3 mg mL–1 and corresponding chitosan concentration of 0.6 mg mL–1, that were set 
based on our previous studies. Namely, MCP and NLCP systems were shown to exhibit 
antimicrobial effect and fibroblast cell line compatibility at selected melatonin and chi-
tosan concentrations  (17, 18). Non-treated cells incubated in HBSS (pH 7.4 or 6.3) served as 
control. After the 2-hour treatment, cells were washed with HBSS pH 7.4 and incubated 
with serum-free medium. The closure of the scratch (in vitro wound healing) was moni-
tored over 24 h using an inverted microscope (5× magnification; Olympus CKX41) equipped 
with a camera (Samsung, 16 MP, f/1.9). To measure the rate of scratch closure, the difference 
between wound area at time 0 and after 24 h was determined. Each well was marked below 
the plate surface by drawing a vertical line, to enable exploration and evaluation of the 
same scratched zone. Scratch area was estimated using ImageJ software (National Insti-
tutes of Health, USA). Wound healing rate (WHR) was expressed as a percentage of the 









where A0 is the scratch area at time 0, and A24 is the corresponding scratch area at 24 h. The 
values shown are the means of three wells from three independent experiments.
Statistical analysis
Statistical data analyses were performed on all in vitro data by one-way analysis of 
variance (ANOVA) followed by multiparametric Tukey’s post hoc test with p < 0.05 as the 
minimal level of significance. Calculations were performed using GraphPad Prism 
software (GraphPad Software, Inc., USA).
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RESULTS AND DISCUSSION
Physico-chemical characteristics of melatonin loaded (NLC enriched) microspheres
NLC free an NLC enriched microspheres were successfully prepared by spray drying 
method. Main characteristics of the microspheres (mean diameter, zeta potential and 
moisture content) are reported in Table II.
Mean diameter of MLCP was higher than the mean diameter of MCP (3.3 vs. 2.7 µm, 
Table II). During the six-month storage at both conditions (5 °C and 25 °C/60 % RH), no 
significant changes in particle size for both samples were observed. This is in agreement 
with the literature report on accelerated stability studies of chitosan-based spray dried 
microspheres conducted at 40 ± 2 °C and 75 ± 5 % RH for a period of 3 months (28).
Both types of microspheres were initially characterised with positive surface charge 
due to the presence of chitosan at the microsphere surface, with lower values for MLCP 
due to the presence of negatively charged lipids in the system. Although slight changes in 
zeta potential during storage were observed for both samples, the decrease was shown not 
to be significant (Table II).
MCP had lower initial moisture content compared to MLCP (Table II), which could be 
explained by higher inlet temperature employed (145 °C vs. 110 °C, respectively) during 
spray drying. Higher inlet temperature resulted in higher outlet temperature and conse-
quent lower moisture content of the MCP microspheres at the end of the drying process 
(21). However, upon storage, moisture content of MCP increased by ~20 % for samples kept 
at 5 °C and by ~40 % for samples kept at 25 °C/60 % RH. No change in the moisture content 
Table II. Characteristics of melatonin-loaded NLC free microspheres (MCP) and melatonin-loaded NLC 
enriched microspheres (MLCP) during stability testinga
Time (month)
Mean diameter (µm) Zeta potential (mV) Moisture content ( %)
MCP MLCP MCP MLCP MCP MLCP
start 2.7 ± 0.3 3.3 ± 0.2b 29.0 ± 2.0 26.6 ± 0.5 b 2.5 ± 0.1 4.7 ± 0.1b
Stored at 5 °C
1 2.7 ± 0.9 3.2 ± 0.4 25.3 ± 1.0 26.1 ± 0.5 3.0 ± 0.1 4.4 ± 0.1
2 2.6 ± 0.4 3.0 ± 0.2 29.9± 0.8 26.4 ± 0.9 3.0 ± 0.1 4.4 ± 0.2
3 2.6 ± 0.1 3.1 ± 0.3 26.8 ± 2.8 25.7 ± 1.1 2.9 ± 0.2 4.5 ± 0.1
6 2.6 ± 0.5 3.2 ± 0.5 25.9 ± 3.8 25.3 ± 1.0 3.1 ± 0.3 4.5 ± 0.1
Stored at 25 °C/60 % RH
1 2.8 ± 0.0 3.3 ± 0.3 23.0 ± 0.5 25.9 ± 0.7 3.4 ± 0.1 4.5 ± 0.2
2 2.4 ± 0.8 3.4 ± 0.4 24.6 ± 1.1 26.0 ± 0.4 3.6 ± 0.6 4.6 ± 0.2
3 2.5 ± 0.8 3.2 ± 0.3 24.6 ± 1.8 25.4 ± 0.5 3.5 ± 0.1 4.5 ± 0.0
6 2.4 ± 0.3 3.4 ± 0.5 23.7 ± 0.7 25.1 ± 1.1 ± 0.1 4.5 ± 0.2
a mean values ± SD, n = 3
b Characterization results at the start of testing for MLCP have already been reported by Duvnjak Romić et al. (18).
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for MLCP microspheres was observed, regardless of the storage conditions employed. It is 
well known that chitosan’s positively charged amino groups are prone to capture water 
(29). Lower water sorption of MLCP microspheres in comparison to MCP microspheres 
might be explained by the interaction between positively charged chitosan and negatively 
charged lipids acting as matrix stabilizing agents. Although ionic interactions between 
components were not previously detected, weak ionic associations that manifest as lower 
positive zeta potential in case of MLCP microspheres could be present (18).
It is known that melatonin is susceptible to degradation on exposure to air and light 
(30), while when formulated in dosage form, its stability is improved (31). Thus, melatonin 
content in microspheres was determined after six-month storage. In the case of MCP 
 sample, no changes in melatonin content were observed. Samples stored refrigerated and 
at room temperature contained more than 97 % of the melatonin at the end of the testing 
period. The MLCP microspheres showed a slight decrease in content, with 93 % melatonin 
remaining in the MLCP microspheres after 6 months at 5 °C and 91 % under room condi-
tions.
Thermal characteristics of melatonin loaded NLC free and NLC enriched microspheres
Thermal analyses of microspheres were employed in order to determine and monitor 
components’ behaviour and interactions during storage. Crystalline melatonin is charac-
terized by an endothermic peak (melting point, Tm) appearing at midpoint temperature of 
Fig. 1. DSC thermographs of melatonin loaded microspheres (MCP) immediately after the preparation 
(1), and after one (2), two (3), three (4) and six months (5) at 5 ± 3 °C.
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117.88 °C with the heat of fusion of 140.2 J g–1 (17). Melatonin melting point in MCP imme-
diately upon the preparation is detected at 110.57 °C (Fig. 1 and 2), which indicates an in-
teraction of the drug with polymers (chitosan and lipids). The decrease in heat of fusion of 
melatonin in microspheres indicates the occurrence of partially amorphous melatonin due 
to the spray drying process (17). Therefore, midpoint temperature and heat of fusion were 
used as indicators of the melatonin state in the MCP during storage. In the Fig. 1 it can be 
seen that throughout the storage time at 5 °C, Tm and heat of fusion values increase, as a 
sign of the progressive transformation of amorphous melatonin to the crystalline state.
Fig. 2 presents the thermographs of the MCP throughout storage at 25 °C/60 % RH. 
Although the shift of melting point towards higher temperature is observed, the heat of 
fusion does not change significantly over time indicating improved stability of the MCP at 
a higher temperature. As microspheres contain a moderate amount of moisture, Pluronic® 
F127 could easily be dissolved at low temperatures (32). This effect could lead to the disso-
lution of amorphous melatonin and consequent precipitation as crystalline material when 
the temperature increases. The above hypothesis could explain improved MCP stability 
when stored at room temperature.
Thermographs of MLCP samples were characterized by an additional endothermic 
peak attributed to the melting point (Tm) of solid lipid Compritol® 888 ATO (Figs. 3 and 4). 
Compared to pure Compritol® 888 ATO that has Tm at 70.3 °C (18), the shift of the melting 
point towards lower temperature was observed in MLCPs. When formulated in NLCs, 
solid lipids are organised in less ordered structures, thus promoting the inclusion of drug 
Fig. 2. DSC thermographs of melatonin loaded microspheres (MCP) immediately after the preparation 
(1) and after one (2), two (3), three (4) and six months (5) at 25 °C/60 % RH.
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molecules and enhancing drug stability (33). Therefore, the shift in Tm for Compritol® 888 
ATO demonstrates the presence of NLCs within the microspheres. Considering the latter, 
Tm and heat of fusion for both, melatonin and Compritol® 888 ATO were evaluated during 
MLCP stability study.
Fig. 3 represents thermographs of MLCP samples stored for 6 months at 5 °C. It was 
observed that no significant changes in Tm or heat of fusion for both melatonin and Com-
pritol® 888 ATO occurred. Results indicate that after six months there was no change in the 
crystalline state of melatonin and that lipids still existed in the form of NLCs within the 
microspheres.
When stored at room temperature (Fig. 4), change in the state of Compritol® 888 ATO 
to the most stable form occurred, which is indicated with an increase in Tm and the heat of 
fusion. At the same time, there was no significant change in Tm and heat of fusion related 
to melatonin. Observed data showed that decomposition of NLC within microspheres 
progressed with time at 25 °C/60 % RH, while there was no significant change in melatonin 
state or content.
In vitro scratch wound healing assay
In vitro scratch wound healing assay was carried out to evaluate the effect of deve lo ped 
MCP and MLCP microspheres on fibroblast migration/proliferation and consequent wound 
repair potential. Microspheres were dispersed in HBSS buffer set to physiologically 
Fig. 3. DSC thermographs of melatonin loaded NLC enriched microspheres (MLCP) immediately 
after the preparation (1) and after one (2), two (3), three (4) and six months (5) at 5 ± 3 °C.
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 relevant pH 7.4 and pH 6.3, that has been measured in the bacterial broth (17). Although it 
was postulated that an increase in wound bed pH indicates contamination and interrup-
tion in healing (35), lower micro-environmental pH milieu is expected for saccharolytic 
Fig. 4. DSC thermographs of melatonin loaded NLC enriched microspheres (MLCP) immediately 
after the preparation (1) and after one (2), two (3), three (4) and six months (5) at 25 °C/60 % RH.
Fig. 5. Influence of melatonin loaded microspheres (MCP) and melatonin loaded NLC enriched 
microspheres (MLCP) dispersed in HBSS (pH 7.4 or 6.3) on scratch wound healing (mean values ± SD, 
n = 3). The wound closure rate is expressed as the percentage of scratch closure after 24 h compared 
to the initial area (0 h). Controls refer to untreated cells incubated in HBSS medium (pH 7.4 or 6.3).
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bacterial infections (36). Our group has previously reported biocompatibility of MCP and 
MLCP systems with human skin cell lines at both pH levels, namely pH 7.4 and pH 6.3 (17, 
18). Results presented in Fig. 5 reveal that MPC and MLPC accelerated wound healing 
when compared to the control in the 24-h period after cell treatment. These results indicate 
that developed systems retained the healing potential of the main components reported 
previously by other researchers (27, 37–39).
Although improvement in wound healing rate after treatment at pH 7.4 was observed, 
it was not found significant. However, major improvement of scratch closure was obtained 
at pH 6.3, indicating the beneficial effect of partially solubilized chitosan in slightly acidic 
conditions. Proliferation/migration of untreated fibroblasts incubated in HBSS at pH 6.3 
(Control pH 6.3; Fig. 5) was the lowest among all the tested variants. Due to the simplicity 
of the scratch assay, replicating only a limited segment of the tissue structure and function 
of the wound bed, higher susceptibility of cell monolayer to non-physiological pH is antici-
pated. Therefore, healing of model wounds treated with microsphere suspensions in HBSS 
at pH 6.3 (MCP pH 6.3 and MLCP pH 6.3, Fig. 5) was also evaluated in comparison to the 
untreated model wound incubated in HBSS at pH 7.4 (Control pH 7.4; Fig. 5). Even in that 
case, the improved closure of wound treated with MLCP was found significant. More 
prominent wound closure for cells treated with MLCP in relation to MCP signifies the 
beneficial effect of lipids in the system. A similar concept where NLCs acted as an accom-
panying healing factor in the wound dressing was recently proposed and confirmed by 
other researchers (40, 41).
CONCLUSIONS
In this study, long term stability of NLC enriched and NLC free microspheres was 
assessed at refrigerated (5 ± 3 °C) and room temperature (25 ± 2 °C/60 ± 5 % RH) over a six- 
-month period. Both systems showed good stability in general, with NLC free micro-
spheres favouring storage at room temperature due to better preservation of amorphous 
melatonin. Oppositely, the lower temperature is the condition of choice for long term stor-
age in case of NLC enriched microspheres, as a result of improved conservation of lipid 
nano system. In vitro scratch wound healing assay showed the respectable potential of devel-
oped systems for application as a functional wound dressing.
Acknowledgments. – This research was supported by PLIVA Croatia Ltd, TEVA Group Member, 
as part of the project “Melatonin-loaded chitosan (nano)systems”.
REFERENCES
 1.  R. G. Frykberg and J. Banks, Challenges in the treatment of chronic wounds, Adv. Wound Care 4 
(2015) 560–582; https://doi.org/10.1089/wound.2015.0635
 2.  T. Shipperley, C. Martin and B. Healthcare, The physiology of wound healing : an emergency re-
sponse, Surg. 35 (2011) 8–10; http://www.sciencedirect.com/science/article/pii/S0263931917301369
 3.  K. Kaplani, S. Koutsi, V. Armenis, F. G. Skondra, N. Karantzelis, S. Champeris Tsaniras and S. 
Taraviras, Wound healing related agents: Ongoing research and perspectives, Adv. Drug Deliv. 
Rev. (2018); https://doi.org/10.1016/j.addr.2018.02.007
646
M. Duvnjak Romić et al.: Evaluation of stability and in vitro wound healing potential of melatonin loaded (lipid enriched) chitosan 
based microspheres, Acta Pharm. 69 (2019) 635–648.
 
 4.  Y.-K. Wu, N.-C. Cheng and C.-M. Cheng, Biofilms in chronic wounds: pathogenesis and diagnosis, 
Trends Biotechnol. 37 (2019) 505–517; https://doi.org/10.1016/j.tibtech.2018.10.011
 5.  R. J. Reiter, D.-X. Tan, L. Fuentes-Broto and M. Luciano, Chapter 8 – Melatonin: A multitasking 
molecule, Progress in Brain Res. 181 (2010) 127–151; https://doi.org/10.1016/S0079-6123(08)81008-4
 6.  R. Hardeland, A. T. Slominski, R. M. Slominski, R. J. Reiter, M. A. Zmijewski and R. Paus, Melatonin: 
A cutaneous perspective on its production, metabolism, and functions, J. Invest. Dermatol. 138 (2018) 
490–499; https://doi.org/10.1016/j.jid.2017.10.025
 7.  A. Crooke, A. Guzman-Aranguez, A. Mediero, P. Alarma-Estrany, G. Carracedo, T. Pelaez, A. Peral 
and J. Pintor, Effect of melatonin and analogues on corneal wound healing: involvement of Mt2 
melatonin receptor, Curr. Eye Res. 40 (2015) 56–65; https://doi.org/10.3109/02713683.2014.914540
 8.  R. Song, L. Ren, H. Ma, R. Hu, H. Gao, L. Wang, X. Chen, Z. Zhao and J. Liu, Melatonin promotes 
diabetic wound healing in vitro by regulating keratinocyte activity, Am. J. Transl. Res. 8 (2016) 4682–
4693.
 9.  R. Murali, P. Thanikaivelan and K. Cheirmadurai, Melatonin in functionalized biomimetic 
constructs promotes rapid tissue regeneration in Wistar albino rats, J. Mater. Chem. B 4 (2016) 5850; 
https://doi.org/10.1039/c6tb01221c.
10.  I. Garcia-Orue, J. L. Pedraz, R. M. Hernandez and M. Igartua, Nanotechnology-based delivery 
 systems to release growth factors and other endogenous molecules for chronic wound healing, 
J. Drug Deliv. Sci. Technol. 42 (2017) 2–17; https://doi.org/10.1016/j.jddst.2017.03.002
11.  J. Pardeike, A. Hommoss and R. H. Müller, Lipid nanoparticles (SLN, NLC) in cosmetic and 
pharmaceutical dermal products, Int. J. Pharm. 366 (2009) 170–184; https://doi.org/10.1016/j.
ijpharm.2008.10.003
12.  G. Gainza, M. Pastor, J. J. Aguirre, S. Villullas, J. L. Pedraz, R. M. Hernandez and M. Igartua, A novel 
strategy for the treatment of chronic wounds based on the topical administration of rhEGF-loaded 
lipid nanoparticles: In vitro bioactivity and in vivo effectiveness in healing-impaired db/db mice, 
J. Control. Release 185 (2014) 51–61; https://doi.org/10.1016/j.jconrel.2014.04.032
13.  N. Karimi, B. Ghanbarzadeh, H. Hamishehkar, B. Mehramuz and H. S. Kafil, Antioxidant, 
antimicrobial and physicochemical properties of turmeric extract-loaded nanostructured lipid 
carrier (NLC), Colloid. Interface Sci. Commun. 22 (2018) 18–24; https://doi.org/10.1016/j.colcom.2017.11.006
14.  F. Saporito, G. Sandri, M. C. Bonferoni, S. Rossi, C. Boselli, A. I. Cornaglia, B. Mannucci, P. Grisoli, 
B. Vigani and F. Ferrari, Essential oil-loaded lipid nanoparticles for wound healing, Int. J. Nanomed. 
13 (2018) 175–186; https://doi.org/10.2147/IJN.S152529
15.  Z. Ma, A. Garrido-Maestu and K. C. Jeong, Application, mode of action, and in vivo activity of 
chitosan and its micro- and nanoparticles as antimicrobial agents: A review, Carbohydr. Polym. 176 
(2017) 257–265; https://doi.org/10.1016/j.carbpol.2017.08.082
16.  V. Patrulea, V. Ostafe, G. Borchard and O. Jordan, Chitosan as a starting material for wound healing 
applications, Eur. J. Pharm. Biopharm. (2015); https://doi.org/10.1016/j.ejpb.2015.08.004
17.  M. Duvnjak Romić, M. Š. Klarić, J. Lovrić, I. Pepić, B. Cetina-Čižmek, J. Filipović-Grčić and A. 
Hafner, Melatonin-loaded chitosan/Pluronic® F127 microspheres as in situ forming hydrogel: An 
innovative antimicrobial wound dressing, Eur. J. Pharm. Biopharm. 107 (2016) 67–79; https://doi.
org/10.1016/j.ejpb.2016.06.013
18.  M. Duvnjak Romić, D. Špoljarić, M. Š. Klarić, B. Cetina-Čižmek, J. Filipović-Grčić and A. Hafner, 
Melatonin loaded lipid enriched chitosan microspheres – Hybrid dressing for moderate exuding 
wounds, J. Drug Deliv. Sci. Technol. (2019); https://doi.org/10.1016/j.jddst.2019.05.004
19.  B. N. Estevinho, F. Rocha, L. Santos and A. Alves, Microencapsulation with chitosan by spray dry-
ing for industry applications – A review, Trends Food Sci. Technol. 31 (2013) 138–155; https://doi.
org/10.1016/j.tifs.2013.04.001
647
M. Duvnjak Romić et al.: Evaluation of stability and in vitro wound healing potential of melatonin loaded (lipid enriched) chitosan 
based microspheres, Acta Pharm. 69 (2019) 635–648.
 
20.  B. R. P. Cabral, P. M. de Oliveira, G. M. Gelfuso, T. de S. C. Quintão, J. A. Chaker, M. G. de O. 
Karnikowski and E. F. Gris, Improving stability of antioxidant compounds from Plinia cauliflora 
(jabuticaba) fruit peel extract by encapsulation in chitosan microparticles, J. Food Eng. 238 (2018) 
195–201; https://doi.org/10.1016/j.jfoodeng.2018.06.004
21.  D. P. Gaspar, M. M. Gaspar, C. V. Eleutério, A. Grenha, M. Blanco, L. M. D. Gonçalves, P. Taboada, 
A. J. Almeida and C. Remunán-López, Microencapsulated solid lipid nanoparticles as a hybrid 
platform for pulmonary antibiotic delivery, Mol. Pharmaceutics 14 (2017) 2977–2990; https://doi.
org/10.1021/acs.molpharmaceut.7b00169
22.  T. Wang, Q. Hu, M. Zhou, J. Xue and Y. Luo, Preparation of ultra-fine powders from polysaccharide-
coated solid lipid nanoparticles and nanostructured lipid carriers by innovative nano spray drying 
technology, Int. J. Pharm. 511 (2016) 219–222; https://doi.org/10.1016/j.ijpharm.2016.07.005
23.  H. Salminen, J. Ankenbrand, B. Zeeb, G. Badolato Bönisch, C. Schäfer, R. Kohlus and J. Weiss, 
Influence of spray drying on the stability of food-grade solid lipid nanoparticles, Food Res. Int. 119 
(2018) 741–750; https://doi.org/10.1016/j.foodres.2018.10.056
24.  D. G. Sami, H. H. Heiba and A. Abdellatif, Wound healing models: A systematic review of animal 
and non-animal models, Wound Med. 24 (2019) 8–17; https://doi.org/10.1016/j.wndm.2018.12.001
25.  A. Stunova and L. Vistejnova, Dermal fibroblasts – A heterogeneous population with regulatory 
function in wound healing, Cytokine Growth Factor Rev. 39 (2018) 137–150; https://doi.org/10.1016/j.
cytogfr.2018.01.003
26.  I. Rubelj, Telomere Q-PNA-FISH – reliable results from stochastic signals, PLoS One 9 (2014) e92559; 
https://doi.org/10.1371/journal.pone.0092559
27.  F. Felice, Y. Zambito, E. Belardinelli, A. Fabiano, T. Santoni and R. Di Stefano, Effect of different 
chitosan derivatives on in vitro scratch wound assay: A comparative study, Int. J. Biol. Macromol. 76 
(2015) 236–241; https://doi.org/10.1016/j.ijbiomac.2015.02.041
28.  A. D. Kulkarni, D. B. Bari, S. J. Surana and C. V Pardeshi, In vitro, ex vivo and in vivo performance 
of chitosan-based spray-dried nasal mucoadhesive microspheres of diltiazem hydrochloride, 
J. Drug Deliv. Sci. Technol. 31 (2016) 108–117; https://doi.org/10.1016/j.jddst.2015.12.004
29.  S. Demarger-Andre and A. Domard, Chitosan carboxylic acid salts in solution and in the solid state, 
Carbohydr. Polym. 23 (1994) 211–219; https://doi.org/10.1016/0144-8617(94)90104-X
30.  N. El Moussaoui and A. Bendriss, The influence of storage conditions on melatonin stability, Int. J. 
Eng. Res. Technol. 3 (2014) 2243–2246.
31.  M. Friciu, T. Savji, S. Zaraa and G. Leclair, Evaluation of stability of melatonin in extemporaneously 
compounded oral suspensions, J. Pharm. Pract. Res. 46 (2016) 28–33; https://doi.org/10.1002/jppr.1171
32.  P. Linse and M. Malmsten, Temperature-dependent micellization in aqueous block copolymer 
solutions, Macromolecules 25 (1992) 5434–5439; https://doi.org/10.1021/ma00046a048
33.  A. Garcês, M. H. Amaral, J. M. Sousa Lobo and A. C. Silva, Formulations based on solid lipid 
nanoparticles (SLN) and nanostructured lipid carriers (NLC) for cutaneous use: A review, Eur. J. 
Pharm. Sci. 112 (2018) 159–167; https://doi.org/10.1016/j.ejps.2017.11.023
34.  B. M. Dulmovits and I. M. Herman, Microvascular remodeling and wound healing: A role for 
pericytes, Int. J. Biochem. Cell Biol. 44 (2012) 1800–1812; https://doi.org/10.1016/j.biocel.2012.06.031
35.  S. L. Percival, S. McCarty, J. A. Hunt, E. J. Woods, The effects of pH on wound healing, biofilms, and 
antimicrobial efficacy, Wound Rep. Reg. 22 (2014) 174–186; https://doi.org/10.1111/wrr.12125
36.  D. B. Friedman, D. L. Stauff, G. Pishchany, C. W. Whitwell, V. J. Torres and E. P. Skaar, Staphylococcus 
aureus redirects central metabolism to increase iron availability, PLoS Pathog. 2 (2006) 0777–0789; 
https://doi.org/10.1371/journal.ppat.0020087
37.  X. Chen, L. H. Peng, Y. H. Shan, N. Li, W. Wei, L. Yu, Q. M. Li, W. Q. Liang and J. Q. Gao, Astragaloside 
IV-loaded nanoparticle-enriched hydrogel induces wound healing and anti-scar activity through 
topical delivery, Int. J. Pharm. 447 (2013) 171–181; https://doi.org/10.1016/j.ijpharm.2013.02.054
648
M. Duvnjak Romić et al.: Evaluation of stability and in vitro wound healing potential of melatonin loaded (lipid enriched) chitosan 
based microspheres, Acta Pharm. 69 (2019) 635–648.
 
38.  V. Kant, A. Gopal, D. Kumar, A. Gopalkrishnan, N. N. Pathak, N. P. Kurade, S. K. Tandan and D. 
Kumar, Topical pluronic F-127 gel application enhances cutaneous wound healing in rats, Acta 
Histochem. 116 (2014) 5–13; https://doi.org/10.1016/j.acthis.2013.04.010
39.  G. Soybir, C. Topuzlu, Ö. Odabaş, K. Dolay, A. Bilir and F. Köksoy, The effects of melatonin on 
angiogenesis and wound healing, Surg. Today. 33 (2003) 896–901; https://doi.org/10.1007/s00595-003-
2621-3
40.  I. Garcia-Orue, G. Gainza, P. Garcia-Garcia, F. B. Gutierrez, J. J. Aguirre, R. M. Hernandez, A. Delgado 
and M. Igartua, Composite nanofibrous membranes of PLGA/Aloe vera containing lipid nanoparticles 
for wound dressing applications, Int. J. Pharm. (2019); https://doi.org/10.1016/j.ijpharm.2018.12.010.
41.  M. Ghodrati, M. R. Farahpour and H. Hamishehkar, Encapsulation of Peppermint essential oil in 
nanostructured lipid carriers: In-vitro antibacterial activity and accelerative effect on infected wound 
healing, Colloids Surfaces A Physicochem. Eng. Asp. (2019); https://doi.org/10.1016/j.colsurfa.2018.12.043
